Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback